Foreign Languages
B2 Upper Intermediate
B2 Upper IntermediateEnglish
Research Areas
Medicine
Managerial Experience
Articles
All (6)
SCI-E, SSCI, AHCI (3)
SCI-E, SSCI, AHCI, ESCI (6)
ESCI (3)
Scopus (5)
TRDizin (2)
2025
20251. Establishing Age-Gender Specific Reference Values of T and B Lymphocyte Subsets in Healthy Adults Using Flow Cytometry
Kaynak F. T., Yanasik M., ÇINAR S., BEŞIŞIK S., DENİZ G., GELMEZ M. Y.
EXPERIMED
, 2025 (ESCI)
2025
20252. Effect of blood groups on acquired and congenital thrombotic thrombocytopenic purpura and clinical correlation: Multi-center Turkish cohort study
İlteriş Kıkılı C., Ortaboz D., Yanaşık M., AR M. C., Kalayoğlu Beşışık S.
Hematology, Transfusion and Cell Therapy
, vol.47, no.1, 2025 (ESCI)
2020
20203. The Overall Distribution of ABO and Rh (D) Groups in The Most Populous City Istanbul as Representing the Complex Ethnicity of Turkey
YANAŞIK M., TUNÇ T., Huslu M., BEŞIŞIK S.
MEDICAL JOURNAL OF BAKIRKOY
, vol.16, no.4, pp.363-368, 2020 (ESCI)
2011
20114. Effect and Safety of Granulocyte Transfusions in Pediatric Patients With Febrile Neutropenia or Defective Granulocyte Functions
Atay D., Ozturk G., Akcay A., Yanasik M., Anak S., Devecioglu O.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
, vol.33, no.6, 2011 (SCI-Expanded)
2009
20095. Effects of rhG-CSF Plus Dexamethasone on Hemostatic Parameters in Healthy Granulocyte Donors: Role of u-PA and Nitric Oxide
Ekmekci O. B., Ozturk G., Ekmekci H., Atay D., Yanasik M., Anak S., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, vol.15, no.6, pp.689-694, 2009 (SCI-Expanded)
2000
20006. The influence of flow cytometric gating strategy and cell preparation procedures on CD34(+) cell quantification
Yenerel M. N., Budak-Alpdogan T., Kalayoglu-Besisik S., Yanasik M., Sargin D.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
, vol.9, no.1, pp.11-12, 2000 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2021
20211. A Refractory Thrombotic Thrombocytopenic Purpura Case Complicated by Hepatic Sinusoidal Obstruction Syndrome and Successful Management with Defibrotide
Erdem S., Mastanzade M., Altay Dadın S., Yanaşık M., Beşışık S.
ISTH 2021 Congress, Pennsylvania, United States Of America, 17 - 21 July 2021, no.5, pp.630-631, (Summary Text)
2019
20192. Serological weak d phenotypes and RHD genotype frequency among Turkish blood donors
Yanasik M., Besisik S., Ozturk G., Huslu M., Temurhan S., Usta S. A., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text)
2019
20193. Red blood cell alloantibodies in thalassemia major patients: an analysis from Istanbul
Yanasik M., Besisik S., Karaman S., Tugcu D., Karakas Z.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, (Summary Text)
2019
20194. A regional hemovigilance study of transfusion-related adverse events at a university hospital from Istanbul
Kaftancioglu U., Atesmen C., Yanik N., Yanasik M., Kalayoglu S.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85
2018
20185. Multiple red blood cell alloantibodies after blood transfusions in a nonhematologic patient
Yanaşık M., Erdem S., Mastanzade M., Uludağ Ö., Huslu M., Yüksel Kaftancıoğlu Ü., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, no.1, pp.68, (Summary Text)
2017
20176. THE ISOHEMAGGLUTININ TITERS OF BLOOD BANK DONORS: THE EXPERIENCE OF ISTANBUL FACULTY OF MEDICINE
Karakas Z., Soydemir D., Yanasik M., Akcay A., Ozturk G.
22nd Congress of the European-Hematology-Association, Madrid, Spain, 22 - 25 June 2017, vol.102, pp.881, (Summary Text)